Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'androgen independence' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 21 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Miyake, H; Hara, S; Zellweger, T; Kamidono, S; Gleave, ME; Hara, I
      Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells

      MOLECULAR UROLOGY
    2. Smith, MR; Xie, T; Zhou, ZZ; Joshi, I
      Efficacy of treatment with antisense oligonucleotides complementary to immunoglobulin sequences of bcl-2/immunoglobulin fusion transcript in a t(14;18) human lymphoma-scid mouse model

      CLINICAL CANCER RESEARCH
    3. Ito, T; Yamamoto, S; Ohno, Y; Namiki, K; Aizawa, T; Akiyama, A; Tachibana, M
      Up-regulation of neuroendocrine differentiation in prostate cancer after androgen deprivation therapy, degree and androgen independence

      ONCOLOGY REPORTS
    4. Reese, DM
      New agents for prostate cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    5. Heidenreich, A; von Knobloch, R; Hofmann, R
      Current status of cytotoxic chemotherapy in hormone refractory prostate cancer

      EUROPEAN UROLOGY
    6. Zellweger, T; Miyake, H; Cooper, S; Chi, K; Conklin, BS; Monia, BP; Gleave, ME
      Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2 '-O-(2-methoxy)ethyl chemistry

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    7. Glynne-Jones, E; Harper, ME; Seery, LT; James, R; Anglin, I; Morgan, HE; Taylor, KM; Gee, JM; Nicholson, RI
      TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence

      INTERNATIONAL JOURNAL OF CANCER
    8. Ackerstaff, E; Pflug, BR; Nelson, JB; Bhujwalla, ZM
      Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells

      CANCER RESEARCH
    9. Schneider, MR; Zhou, R; Hoeflich, A; Krebs, O; Schmidt, J; Mohan, S; Wolf, E; Lahm, H
      Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    10. Tomita, Y
      Application of antisense technology to urologic cancers

      MOLECULAR UROLOGY
    11. Egawa, S; Takashima, R; Matsumoto, K; Mizoguchi, H; Kuwao, S; Baba, S
      A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    12. Weeraratna, AT; Arnold, JT; George, DJ; DeMarzo, A; Isaacs, JT
      Rational basis for trk inhibition therapy for prostate cancer

      PROSTATE
    13. Thalmann, GN; Sikes, RA; Wu, TT; Degeorges, A; Chang, SM; Ozen, M; Pathak, S; Chung, LWK
      LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis

      PROSTATE
    14. Jongsma, J; Oomen, MHA; Noordzij, MA; Romijn, JC; van der Kwast, TH; Schroder, FH; van Steenbrugge, GJ
      Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

      PROSTATE
    15. Konig, JJ; Teubel, W; van Steenbrugge, GJ; Romijn, JC; Hagemeijer, A
      Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines

      UROLOGICAL RESEARCH
    16. Pflug, BR; Reiter, RE; Nelson, JB
      Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines

      PROSTATE
    17. Rohrbach, H; Haas, CJ; Baretton, GB; Hirschmann, A; Diebold, J; Behrendt, RP; Lohrs, U
      Microsatellite instability and loss of heterozygosity in prostatic carcinomas: Comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases

      PROSTATE
    18. Baretton, GB; Klenk, U; Diebold, J; Schmeller, N; Lohrs, U
      Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression

      BRITISH JOURNAL OF CANCER
    19. DIXON SC; ZALLES A; GIORDANO C; LUSH RM; VENZON D; REED E; FIGG WD
      IN-VITRO EFFECT OF GALLIUM NITRATE WHEN COMBINED WITH KETOCONAZOLE INTHE PROSTATE-CANCER CELL-LINE PC-3

      Cancer letters
    20. ZHU X; LIU JP
      STEROID-INDEPENDENT ACTIVATION OF ANDROGEN RECEPTOR IN ANDROGEN-INDEPENDENT PROSTATE-CANCER - A POSSIBLE ROLE FOR THE MAP KINASE SIGNAL-TRANSDUCTION PATHWAY

      Molecular and cellular endocrinology
    21. SHIRAI T; SANO M; IMAIDA K; TAKAHASHI S; MORI T; ITO N
      DURATION DEPENDENT INDUCTION OF INVASIVE PROSTATIC CARCINOMAS WITH PHARMACOLOGICAL DOSE OF TESTOSTERONE PROPIONATE IN RATS PRETREATED WITH 3,2'-DIMETHYL-4-AMINOBIPHENYL AND DEVELOPMENT OF ANDROGEN-INDEPENDENT CARCINOMAS AFTER CASTRATION

      Cancer letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 11:54:33